Zhengzhou University-First Affiliated Hospital

Zhengzhou, Henan 450003

1 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Disease, Receiving Dialysis, Dialysis, ESRD (End-Stage Renal Disease), Hepatocellular Carcinoma, Hyperphosphatemia

Studies at this site

• A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China — Recruiting now
• A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma — Running, not enrolling